Figure 2 — Oral maintenance therapy using apatinib combined with S-1/capecitabine for esophageal squamous cell carcinoma with residual disease after definitive chemoradiotherapy

Research Paper|Volume 13, Issue 6|pp. 8408–8420

Oral maintenance therapy using apatinib combined with S-1/capecitabine for esophageal squamous cell carcinoma with residual disease after definitive chemoradiotherapy

Back to articleFigure 2(2 of 2)

100%

Figure 2.PFS of patients (A) with CR+PR vs SD after dCRT, (B) with vs without fistula, and (C) with vs without any adverse event; OS of patients with (D) CR+PR vs SD after dCRT, (E) with vs without fistula, and (F) with vs without proteinuria.